Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
- Auteur
- TANNOCK, Ian F1 ; DE WIT, Ronald2 ; ROSENTHAL, Mark A11 ; EISENBERGER, Mario A12 ; BERRY, William R3 ; HORTI, Jozsef4 ; PLUZANSKA, Anna5 ; CHI, Kim N6 ; OUDARD, Stephane7 ; THEODORE, Christine8 ; JAMES, Nicholas D9 ; TURESSON, Ingela10
[1] Department of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto, Toronto, Canada
[2] Department of Medical Oncology, Erasmus University Medical Centre, Rotterdam, Netherlands
[3] Raleigh Hematology Oncology Associates, Cary, N.C., Hungary
[4] Department of Chemotherapy and Clinical Pharmacology, National Institute of Oncology, Budapest, Hungary
[5] Department of Chemotherapy, Medical University, Lodz, Poland
[6] BC Cancer Agency, Vancouver, B.C., Canada
[7] Hôpital Européen Georges Pompidou, Paris, France
[8] Institut Gustav Roussy, Villejuif, France
[9] Cancer Research UK Institute for Cancer Studies, Birmingham, United Kingdom
[10] Section of Oncology, Uppsala University Hospital, Uppsala, Sweden
[11] Cancer Trials Australia, Victoria, Australia
[12] Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, United States - Source
The New England journal of medicine. 2004, Vol 351, Num 15, pp 1502-1512, 11 p ; ref : 29 ref
- CODEN
- NEJMAG
- ISSN
- 0028-4793
- Domaine scientifique
- General medicine general surgery
- Editeur
- Massachusetts Medical Society, Boston, MA
- Pays de publication
- United States
- Type de document
- Article
- Langue
- English
- Mot clé (fr)
- Anticancéreux Antiinflammatoire Docétaxel Immunodépresseur Mitoxantrone Médecine Prednisone Stade avancé Cancer de la prostate Agent alkylant Anthraquinone dérivé Antimitotique Antimétabolite Appareil génital mâle pathologie Appareil urinaire pathologie Corticostéroïde Hormone surrénalienne Prostate pathologie Taxane dérivé Tumeur maligne
- Mot clé (en)
- Antineoplastic agent Antiinflammatory agent Docetaxel Immunosuppressive agent Mitoxantrone Medicine Prednisone Advanced stage Prostate cancer Alkylating agent Anthraquinone derivatives Antimitotic Antimetabolic Male genital diseases Urinary system disease Corticosteroid Adrenal hormone Prostate disease Taxane derivatives Malignant tumor
- Mot clé (es)
- Anticanceroso Antiinflamatorio Docetaxel Inmunodepresor Mitoxantrona Medicina Prednisona Estadio avanzado Cáncer de la próstata Agente alquilante Antraquinona derivado Antimitótico Antimetabólito Aparato genital macho patología Aparato urinario patología Corticoesteroide Hormona suprarrenal Prostata patología Taxane derivado Tumor maligno
- Classification
- Pascal
- 002 Sciences biologiques et medicales / 002B Sciences medicales / 002B14 Nephrologie. Maladies des voies urinaires / 002B14D Tumeurs de l'appareil urinaire / 002B14D02 Voies urinaires. Prostate
- Pascal
- 002 Sciences biologiques et medicales / 002B Sciences medicales / 002B20 Gynecologie. Andrologie. Obstetrique / 002B20B Pathologie de l'appareil génital mâle / 002B20B02 Tumeurs
- Discipline
- Generalities in medical sciences Gynecology. Andrology. Obstetrics Nephrology. Urinary tract diseases
- Provenance
- Inist-CNRS
- Base de données
- PASCAL
- Identifiant INIST
- 16160061
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Accès au Document
Installer sur votre navigateur
DOI
10.1056/NEJMoa040720 
https://dx.doi.org/10.1056/NEJMoa040720
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa040720\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:3:\"351\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"1502\";s:8:\"\u0000*\u0000epage\";s:4:\"1512\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TANNOCK\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ian F\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:14:\"DE WIT, Ronald\";i:1;s:17:\"ROSENTHAL, Mark A\";i:2;s:20:\"EISENBERGER, Mario A\";i:3;s:16:\"BERRY, William R\";i:4;s:13:\"HORTI, Jozsef\";i:5;s:15:\"PLUZANSKA, Anna\";i:6;s:10:\"CHI, Kim N\";i:7;s:16:\"OUDARD, Stephane\";i:8;s:19:\"THEODORE, Christine\";i:9;s:17:\"JAMES, Nicholas D\";i:10;s:16:\"TURESSON, Ingela\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Accès par Panist
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa040720\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:3:\"351\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"1502\";s:8:\"\u0000*\u0000epage\";s:4:\"1512\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TANNOCK\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ian F\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:14:\"DE WIT, Ronald\";i:1;s:17:\"ROSENTHAL, Mark A\";i:2;s:20:\"EISENBERGER, Mario A\";i:3;s:16:\"BERRY, William R\";i:4;s:13:\"HORTI, Jozsef\";i:5;s:15:\"PLUZANSKA, Anna\";i:6;s:10:\"CHI, Kim N\";i:7;s:16:\"OUDARD, Stephane\";i:8;s:19:\"THEODORE, Christine\";i:9;s:17:\"JAMES, Nicholas D\";i:10;s:16:\"TURESSON, Ingela\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Accès par Istex
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa040720\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Accès par Unpaywall
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa040720\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:3:\"351\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"1502\";s:8:\"\u0000*\u0000epage\";s:4:\"1512\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TANNOCK\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ian F\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:14:\"DE WIT, Ronald\";i:1;s:17:\"ROSENTHAL, Mark A\";i:2;s:20:\"EISENBERGER, Mario A\";i:3;s:16:\"BERRY, William R\";i:4;s:13:\"HORTI, Jozsef\";i:5;s:15:\"PLUZANSKA, Anna\";i:6;s:10:\"CHI, Kim N\";i:7;s:16:\"OUDARD, Stephane\";i:8;s:19:\"THEODORE, Christine\";i:9;s:17:\"JAMES, Nicholas D\";i:10;s:16:\"TURESSON, Ingela\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Accès par Europe PubMed Central
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa040720\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:3:\"351\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"1502\";s:8:\"\u0000*\u0000epage\";s:4:\"1512\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TANNOCK\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ian F\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:14:\"DE WIT, Ronald\";i:1;s:17:\"ROSENTHAL, Mark A\";i:2;s:20:\"EISENBERGER, Mario A\";i:3;s:16:\"BERRY, William R\";i:4;s:13:\"HORTI, Jozsef\";i:5;s:15:\"PLUZANSKA, Anna\";i:6;s:10:\"CHI, Kim N\";i:7;s:16:\"OUDARD, Stephane\";i:8;s:19:\"THEODORE, Christine\";i:9;s:17:\"JAMES, Nicholas D\";i:10;s:16:\"TURESSON, Ingela\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Accès par Base Search
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa040720\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:3:\"351\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"1502\";s:8:\"\u0000*\u0000epage\";s:4:\"1512\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TANNOCK\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ian F\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:14:\"DE WIT, Ronald\";i:1;s:17:\"ROSENTHAL, Mark A\";i:2;s:20:\"EISENBERGER, Mario A\";i:3;s:16:\"BERRY, William R\";i:4;s:13:\"HORTI, Jozsef\";i:5;s:15:\"PLUZANSKA, Anna\";i:6;s:10:\"CHI, Kim N\";i:7;s:16:\"OUDARD, Stephane\";i:8;s:19:\"THEODORE, Christine\";i:9;s:17:\"JAMES, Nicholas D\";i:10;s:16:\"TURESSON, Ingela\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Accès par arXiv
